For research use only. Not for therapeutic Use.
Telithromycin(Cat No.:I002452)is a ketolide antibiotic derived from erythromycin, designed to treat respiratory infections like community-acquired pneumonia, acute bronchitis, and sinusitis. It works by binding to bacterial ribosomes and inhibiting protein synthesis, effective against certain macrolide-resistant strains, including Streptococcus pneumoniae and Haemophilus influenzae. Known for its potent action against respiratory pathogens, telithromycin addresses bacterial resistance with its enhanced binding affinity. However, its use is limited due to potential side effects, including hepatotoxicity. Telithromycin remains an option in specific cases where standard antibiotics prove ineffective.
Catalog Number | I002452 |
CAS Number | 191114-48-4 |
Synonyms | HMR 3647;Ketek;RU 66647 |
Molecular Formula | C43H65N5O10 |
Purity | ≥95% |
Solubility | 10 mM in DMSO |
Storage | Store at -20°C |
IUPAC Name | (1S,2R,5R,7R,8R,9R,11R,13R,14R)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-15-[4-(4-pyridin-3-ylimidazol-1-yl)butyl]-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone |
InChI | InChI=1S/C43H65N5O10/c1-12-33-43(8)37(48(41(53)58-43)19-14-13-18-47-23-31(45-24-47)30-16-15-17-44-22-30)27(4)34(49)25(2)21-42(7,54-11)38(28(5)35(50)29(6)39(52)56-33)57-40-36(51)32(46(9)10)20-26(3)55-40/h15-17,22-29,32-33,36-38,40,51H,12-14,18-21H2,1-11H3/t25-,26-,27+,28+,29-,32+,33-,36-,37-,38-,40+,42-,43-/m1/s1 |
InChIKey | LJVAJPDWBABPEJ-PNUFFHFMSA-N |
SMILES | CC[C@@H]1[C@@]2([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H](C(=O)[C@H](C(=O)O1)C)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C |
Reference | 1: Nicolau DP. Clinical use of antimicrobial pharmacodynamic profiles to optimise 2: Lorenz J. Telithromycin: the first ketolide antibacterial for the treatment of <br> 4: Drusano G. Pharmacodynamic and pharmacokinetic considerations in antimicrobial <br> |